REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Suzhou Fushilai Pharmaceutical Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Suzhou Fushilai Pharmaceutical Co.,Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Suzhou Fushilai Pharmaceutical Co., Ltd is mainly engaged in the research and development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. The company's main products include three series of products: lipoic acid series, phosphatidylcholine series, carnosine series. The company was established in 2000 and is headquartered in Changshu City, Jiangsu Province.

Headquarters
No. 16, Haiwang Road, Changshu New Material Industrial Park, Suzhou City, Jiangsu Province
Changshu; Jiangsu; Postal Code: 215500

Contact Details: Purchase the Suzhou Fushilai Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.fuslai.com

Basic Information
Total Employees:
Purchase the Suzhou Fushilai Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Suzhou Fushilai Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Suzhou Fushilai Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Suzhou Fushilai Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
November 27, 2000
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
60.22%
Purchase this report to view the information.
2.41%
Purchase this report to view the information.
0.44%
Purchase this report to view the information.
0.42%
Purchase this report to view the information.
0.38%
Subsidiaries
Fujilai (Shandong) Pharmaceutical Co., Ltd
Suzhou Berg Zhiyuan Investment Management Co., Ltd.
Suzhou Kuntai Biotechnology Co., Ltd.
Company Performance
Financial values in the chart are available after Suzhou Fushilai Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-19.59%▼
Total operating revenue
-16.28%▼
Operating profit (EBIT)
-86.61%▼
Net Profit (Loss) for the Period
-87.08%▼
Total assets
-1.57%▼
Total equity
-2.45%▼
Operating Profit Margin (ROS)
-27.03%▼
Net Profit Margin
-23.14%▼
Return on Equity (ROE)
-4.79%▼
Debt to Equity Ratio
-0.01%▼
Quick Ratio
-1.52%▼
Cash Ratio
-0.45%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Pharmaresources (Shanghai) Co., Ltd.
 
Chengdu Olymvax Biopharmaceuticals Inc.
Cstone Pharmaceuticals
 
Hybio Pharmaceutical Co., Ltd.
Beijing Leadman Biochemistry Co.,Ltd
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo